Drug Database · Clinicians

Mineral oil

Brands: none registered under a distinct brand name (generic name only).

US brand (reference label): FLEET; not a Philippine-registered brand.

Cathartic/Laxative PH FDA category

HR · Household remedy1 PH product
Dispensing: Household remedy (HR) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID e0b7acab-add4-4daf-b1df-bb7cf5ca8e19, version date October 14, 2026 (FLEET · C.B. Fleet Company, Inc.). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • Uses ▪ relieves occasional constipation ▪ generally produces bowel movement in 6 to 8 hours
US FDA label
Full indications and usage US FDA label

Uses ▪ relieves occasional constipation ▪ generally produces bowel movement in 6 to 8 hours

Dosing: Adult

Dosage and administration (US label) US FDA label

Directions ▪ do not take with meals ▪ shake well before using ▪ adults and children 12 years of age and over: 3 to 9 teaspoons (15 - 45 mL), maximum 9 teaspoons (45 mL) in 24 hours ▪ children 6 to under 12 years of age: 1 to 3 teaspoons (5 – 15 mL), maximum 3 teaspoons (15 mL) in 24 hours or as directed by a doctor ▪ children under 6 years of age: consult a doctor

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Registered products in the Philippines

1 product registered with the Food and Drug Administration (FDA) Philippines list Mineral oil as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Mineral oil
Package insert
(no brand name)Mineral Oil
100% w/w Oral SolutionAmber Glass Bottle with Black Polypropylene Screw Cap x 60 mL and 120 mL
HR
Sonneborn Refined ProductsU.S.A
Philusa Corporation
DRHR-2280
Aug 24, 2028

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Warnings/Precautions

Warnings and precautions (US label) US FDA label

Warnings Do not use

  • for children under 6 years of age, pregnant women, bedridden patients or persons with difficulty swallowing Ask a doctor before using this product if you have
  • abdominal pain, nausea or vomiting
  • a sudden change in bowel habits that persists over a period of 2 weeks Ask a doctor or pharmacist before use if you are presently taking a stool softener laxative. When using this product do not take with meals. Stop use and ask a doctor if
  • you notice rectal bleeding or fail to have a bowel movement after use of a laxative. This may indicate a serious condition. Discontinue use and consult a doctor.
  • you need to use the product more than one week If breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. FLEET · C.B. Fleet Company, Inc. [US FDA-approved label, version 2, October 14, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e0b7acab-add4-4daf-b1df-bb7cf5ca8e19
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .